BWXT CEO Rex Geveden Receives Annual Equity Compensation Grants
BWX Technologies, Inc.
Subscribe to track BWXT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
BWXT CEO Rex Geveden Receives Annual Equity Compensation Grants
Company: BWX Technologies, Inc. (BWXT) Form: 4 | Filed: 2026/02/27 Significance: Low (Routine Compensation)
Insider: Geveden Rex D Title: President and CEO | Relationship: Director, Officer
Transaction Details: • Type: Grant (Award) • Security: RSUs & Stock Options • Shares: 23,703 (Combined) • Price: $0.00 (Grant) • Strike Price: $208.27 (Options) • Owned After: 23,703 (Derivative Holdings)
Key Insight: Routine annual executive compensation grant consisting of RSUs and Stock Options vesting over 3 years. Not an open market purchase.
Market Context: Transaction represents <0.03% of shares outstanding for this $18.87B market cap company.
Comprehensive Analysis
SEC Filing Analysis: BWX Technologies, Inc. (BWXT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: CEO Rex Geveden received routine annual equity compensation (RSUs and Options) with a 3-year vesting schedule.
- Market Impact: Neutral; this is standard executive compensation and does not reflect a change in insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | BWX Technologies, Inc. |
| Ticker Symbol | BWXT |
| CIK | 0001486957 |
| Market Cap | $18.87 Billion |
Insider Information
| Field | Value |
|---|---|
| Name | Geveden Rex D |
| CIK | 0001408482 |
| Title/Position | President and CEO |
| Relationship | Director, Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-02-25 |
| Transaction Code | A (Grant/Award) |
| Security Type | RSUs & Stock Options |
| Shares Involved | 23,703 (6,027 RSUs + 17,676 Options) |
| Price Per Share | $0.00 (Option Exercise Price: $208.27) |
| Total Value | $0 (Compensation Grant) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Shares Transacted | 23,703 |
| % of Shares Outstanding | 0.026% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For an $18.87B company, this equity grant is standard operational overhead.
- Dilution Impact: Negligible (0.026% of outstanding shares).
- Vesting Terms: Both RSUs and Options vest in three equal annual installments beginning Feb 25, 2027, ensuring long-term alignment.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-cash transaction representing compensation. The option exercise price of $208.27 likely reflects the fair market value on the grant date.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
- Transaction Notes: The filing reports two separate derivative transactions: 6,027 Restricted Stock Units and 17,676 Employee Stock Options. The options expire in 2036.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
